These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 24243691)

  • 41. [Treatment outcome of non-Hodgkin lymphoma in childhood: KYCCSG NHL-89, 96].
    Fukano R; Suminoe A; Matsuzaki A; Inada H; Nagatoshi Y; Ishii E; Nakayama H; Kawakami K; Moritake H; Yanai F; Itonaga N; Suenobu S; Kikuchi M; Okamura J; Kawano Y
    Rinsho Ketsueki; 2012 Nov; 53(11):1898-905. PubMed ID: 23257670
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Results and conclusions of the European Intergroup EURO-LB02 trial in children and adolescents with lymphoblastic lymphoma.
    Landmann E; Burkhardt B; Zimmermann M; Meyer U; Woessmann W; Klapper W; Wrobel G; Rosolen A; Pillon M; Escherich G; Attarbaschi A; Beishuizen A; Mellgren K; Wynn R; Ratei R; Plesa A; Schrappe M; Reiter A; Bergeron C; Patte C; Bertrand Y
    Haematologica; 2017 Dec; 102(12):2086-2096. PubMed ID: 28983060
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prolonged persistence of PCR-detectable minimal residual disease after diagnosis or first relapse predicts poor outcome in childhood B-precursor acute lymphoblastic leukemia.
    Steenbergen EJ; Verhagen OJ; van Leeuwen EF; van den Berg H; Behrendt H; Slater RM; von dem Borne AE; van der Schoot CE
    Leukemia; 1995 Oct; 9(10):1726-34. PubMed ID: 7564517
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
    Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Retrospective analysis of relapsed or primary refractory childhood lymphoblastic lymphoma in Japan.
    Mitsui T; Mori T; Fujita N; Inada H; Horibe K; Tsurusawa M;
    Pediatr Blood Cancer; 2009 May; 52(5):591-5. PubMed ID: 19156862
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [T-cell pediatric acute lymphoblastic leukemia: analysis of survival and prognostic factors in 4 consecutive protocols of the Spanish cooperative study group SHOP].
    Rives S; Estella J; Camós M; García-Miguel P; Verdeguer A; Couselo JM; Tasso M; Molina J; Gómez P; Fernández-Delgado R; Navajas A; Badell I;
    Med Clin (Barc); 2012 Jul; 139(4):141-9. PubMed ID: 22459573
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cooperative study group for childhood acute lymphoblastic leukaemia (COALL): long-term results of trials 82,85,89,92 and 97.
    Escherich G; Horstmann MA; Zimmermann M; Janka-Schaub GE;
    Leukemia; 2010 Feb; 24(2):298-308. PubMed ID: 20016530
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bone marrow recurrence after initial intensive treatment for childhood acute lymphoblastic leukemia.
    Rivera GK; Zhou Y; Hancock ML; Gajjar A; Rubnitz J; Ribeiro RC; Sandlund JT; Hudson M; Relling M; Evans WE; Pui CH
    Cancer; 2005 Jan; 103(2):368-76. PubMed ID: 15599932
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of glutathione S-transferase gene deletion on early relapse in childhood B-precursor acute lymphoblastic leukemia.
    Takanashi M; Morimoto A; Yagi T; Kuriyama K; Kano G; Imamura T; Hibi S; Todo S; Imashuku S
    Haematologica; 2003 Nov; 88(11):1238-44. PubMed ID: 14607752
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The influence of maximum supportive care on dose compliance and survival. Single-center analysis of childhood acute lymphoblastic leukemia and non-Hodgkin's-lymphoma treated within 1984-1993.
    Urban C; Benesch M; Lackner H; Schwinger W; Kerbl R; Gadner H
    Klin Padiatr; 1997; 209(4):235-42. PubMed ID: 9293456
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Survival in adults with acute lymphoblastic leukaemia].
    Tangen JM; Fløisand Y; Haukås E; Naess IA; Skjelbakken T; Stapnes C; Tjønnfjord GE
    Tidsskr Nor Laegeforen; 2010 Sep; 130(17):1710-3. PubMed ID: 20835280
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A childhood chemotherapy protocol improves overall survival among adults with T-lymphoblastic lymphoma.
    Zhu MY; Wang H; Huang CY; Xia ZJ; Chen XQ; Geng QR; Wang WD; Wang L; Lu Y
    Oncotarget; 2016 Jun; 7(25):38884-38891. PubMed ID: 27150061
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Superior vena cava syndrome and poor performance status at presentation affect survival in mediastinal T-lymphoblastic lymphoma--a single institute experience from India.
    Tilak TV; Raina V; Kumar L; Sharma A; Sharma MC; Vishnubhatla S; Bakhshi S
    Ann Hematol; 2013 Jul; 92(7):917-23. PubMed ID: 23515709
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term results of Taiwan Pediatric Oncology Group studies 1997 and 2002 for childhood acute lymphoblastic leukemia.
    Liang DC; Yang CP; Lin DT; Hung IJ; Lin KH; Chen JS; Hsiao CC; Chang TT; Peng CT; Lin MT; Chang TK; Jaing TH; Liu HC; Wang LY; Yeh TC; Jou ST; Lu MY; Cheng CN; Sheen JM; Chiou SS; Wu KH; Hung GY; Chen RL; Chen SH; Cheng SN; Chang YH; Chen BW; Ho WL; Wang JL; Lin ST; Hsieh YL; Wang SC; Chang HH; Yang YL; Huang FL; Chang CY; Chang WH; Lin KS
    Leukemia; 2010 Feb; 24(2):397-405. PubMed ID: 20016538
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system recurrence and improves survival in aggressive non-hodgkin lymphoma.
    Tomita N; Kodama F; Kanamori H; Motomura S; Ishigatsubo Y
    Cancer; 2002 Aug; 95(3):576-80. PubMed ID: 12209750
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential impact of asparaginase discontinuation on outcomes of children with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.
    Ishida H; Imamura T; Kobayashi R; Hashii Y; Deguchi T; Miyamura T; Oda M; Yamamoto M; Okada K; Sano H; Koh K; Yuza Y; Watanabe K; Nishimura N; Takimoto T; Moriya-Saito A; Sekimizu M; Suenobu S; Sunami S; Horibe K
    Cancer Med; 2024 Jun; 13(12):e7246. PubMed ID: 38888368
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The prognosis and survival of childhood acute lymphoblastic leukemia with central nervous system relapse.
    Unal S; Yetgin S; Cetin M; Gümrük F; Arslan D; Ozyürek E; Tuncer M; Topçu M
    Pediatr Hematol Oncol; 2004; 21(3):279-89. PubMed ID: 15202168
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Analysis of clinical features and prognostic significance of childhood T-lineage acute lymphoblastic leukemia].
    Zhang YL; Zhao WL; Nie SS; Guo DD; Ji ZH; Chai YH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1496-500. PubMed ID: 22169311
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
    Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
    [TBL] [Abstract][Full Text] [Related]  

  • 60. T-cell lymphoblastic lymphoma and T-cell acute lymphoblastic leukemia: a separate entity?
    Hoelzer D; Gökbuget N
    Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S214-21. PubMed ID: 19778844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.